GAGANDEEP BAL: Open Payments
NPI 1578072245 · RIDGELAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,280 in 133 payments from 26 companies in 2025. Trend: 2023 $2,784 · 2024 $2,409 · 2025 $2,280
Food & beverage: $2,280
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $303 |
| Novo Nordisk Inc | 23 | $300 |
| Axsome Therapeutics, Inc. | 16 | $282 |
| AstraZeneca Pharmaceuticals LP | 7 | $177 |
| Corcept Therapeutics | 9 | $157 |
| Lundbeck LLC | 8 | $151 |
| Radius Health, Inc. | 5 | $139 |
| Lilly USA, LLC | 11 | $131 |
| Novartis Pharmaceuticals Corporation | 6 | $106 |
| Amgen Inc. | 6 | $99 |
Products named: Sunosi, UBRELVY, FARXIGA, Korlym, VYEPTI, MOUNJARO, Wegovy, Rybelsus.
Industry payments across MS — which companies pay providers there.
